Annual Total Liabilities
$3.45 B
-$162.80 M-4.50%
31 December 2023
Summary:
Amneal Pharmaceuticals annual total liabilities is currently $3.45 billion, with the most recent change of -$162.80 million (-4.50%) on 31 December 2023. During the last 3 years, it has fallen by -$208.54 million (-5.70%). AMRX annual total liabilities is now -5.70% below its all-time high of $3.66 billion, reached on 31 December 2020.AMRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$3.49 B
-$19.33 M-0.55%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly total liabilities is currently $3.49 billion, with the most recent change of -$19.33 million (-0.55%) on 30 September 2024. Over the past year, it has dropped by -$1.04 million (-0.03%). AMRX quarterly total liabilities is now -12.36% below its all-time high of $3.99 billion, reached on 31 March 2020.AMRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -4.5% | -0.0% |
3 y3 years | -5.7% | -2.7% |
5 y5 years | -0.1% | +5.6% |
AMRX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -5.7% | at low | -9.2% | +1.2% |
5 y | 5 years | -5.7% | +4.0% | -12.4% | +5.6% |
alltime | all time | -5.7% | +101.0% | -12.4% | +103.5% |
Amneal Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $3.49 B(-0.6%) |
June 2024 | - | $3.51 B(+1.2%) |
Mar 2024 | - | $3.47 B(+0.6%) |
Dec 2023 | $3.45 B(-4.5%) | $3.45 B(-1.2%) |
Sept 2023 | - | $3.50 B(-0.6%) |
June 2023 | - | $3.52 B(+1.5%) |
Mar 2023 | - | $3.46 B(-4.2%) |
Dec 2022 | $3.62 B(+1.2%) | $3.62 B(-1.1%) |
Sept 2022 | - | $3.66 B(-5.0%) |
June 2022 | - | $3.85 B(+10.6%) |
Mar 2022 | - | $3.48 B(-2.6%) |
Dec 2021 | $3.57 B | $3.57 B(-0.5%) |
Sept 2021 | - | $3.59 B(-1.1%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $3.63 B(+1.1%) |
Mar 2021 | - | $3.59 B(-1.9%) |
Dec 2020 | $3.66 B(+10.3%) | $3.66 B(-0.8%) |
Sept 2020 | - | $3.69 B(+0.1%) |
June 2020 | - | $3.69 B(-7.6%) |
Mar 2020 | - | $3.99 B(+20.1%) |
Dec 2019 | $3.32 B(-4.0%) | $3.32 B(+0.3%) |
Sept 2019 | - | $3.31 B(-5.8%) |
June 2019 | - | $3.51 B(-2.0%) |
Mar 2019 | - | $3.58 B(+3.7%) |
Dec 2018 | $3.46 B(+101.2%) | $3.46 B(-5.7%) |
Sept 2018 | - | $3.67 B(+1.7%) |
June 2018 | - | $3.61 B(+109.9%) |
Dec 2017 | $1.72 B | $1.72 B |
FAQ
- What is Amneal Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual total liabilities year-on-year change?
- What is Amneal Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly total liabilities year-on-year change?
What is Amneal Pharmaceuticals annual total liabilities?
The current annual total liabilities of AMRX is $3.45 B
What is the all time high annual total liabilities for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual total liabilities is $3.66 B
What is Amneal Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AMRX annual total liabilities has changed by -$162.80 M (-4.50%)
What is Amneal Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AMRX is $3.49 B
What is the all time high quarterly total liabilities for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly total liabilities is $3.99 B
What is Amneal Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AMRX quarterly total liabilities has changed by -$1.04 M (-0.03%)